BotVax-B (10cc)

BotVax B prevents equine botulism due to Clostridium botulinum Type B which accounts for more than 85% of equine botulism cases. Neogen's BotVax B is a USDA approved vaccine for healthy horses that are exposed for risk factors such as baled hay, horses that travel, horses that get wounded or travel/reside in endemic areas. Horses and foals are susceptible to botulism and symptoms can progress quickly.

Key Benefits

• Clostridium botulinum type B accounts for more than 85% of botulism cases
• Affects both foals and adult horses
• Botulism spores are viable in soil for years
• Horses are exposed due to many risk factors
• USDA approved vaccine

How It Works

• Purified botulinum type B toxoid, aluminum phosphate absorbed
• Thimerosal (as preservative) 0.01%
• Formaldehyde (as inactivating solution) < 1.12%

Indications

BotVax B is a USDA approved monovalent vaccine (toxoid) for the prevention of equine botulism Type B due to Clostridium botulinum in healthy horses.

This product does not confer protection against other C. botulinum toxin types.

View BotVax-B Drug Facts Sheet.

Shake well before use.

• Inject 2 mL intramuscularly, using aseptic technique, at monthly intervals for a total of 3 doses.
• Booster annually with a single 2 mL intramuscular dose.

Research has demonstrated that pregnant mares immunized during the third trimester of gestation, with the third dose (booster) given 2-4 weeks before parturition, respond with antibody. This antibody is concentrated in colostrum and results in significant passively acquired antibody in normal suckling foals.

Caution:

Do not vaccinate food-producing animals within 21 days of slaughter.Local reactions at the injection site, such as heat and minor swelling, may occur. Anaphylactic reactions may occur.

Warning:

For veterinary use only. Not for human use. For animal use only. Keep out of reach of children.

Storage:

Store unopened vials at 2°-7°C (35°-45°F). DO NOT FREEZE. Use the entire contents of the container when first opened. Do not store opened vials.

Precautions:

Anaphylactoid reactions may occur. Epinephrine is antidotal.

Clostridium botulinum Type B Toxoid Vaccine for Horses

Prevention is the best defense

• Botulinum toxins are among the most deadly toxins in the world.
• Horses are extremely sensitive compared to other species.
• Time is a critical factor due to the rapid and severe progression of this neuroparalytic disease.
• Vaccination is far less expensive than treatment, which can exceed $10,000 with no guarantee for survival.

Clostridium botulinum type B

• Accounts for more than 85% of equine botulism cases
• Strikes both adult horses and foals rapidly and is most often fatal
• Several studies place the mortality rate around 70%
• Produces spores in soils worldwide that remain viable for many years
• Closely related to Clostridium tetani, but is much more deadly

Risk factors

• Any baled hay (round, square, big or small), haylage or silage products
• Horses and foals that reside, in or travel to, endemic areas
• Horses that travel for shows, races, and other equine events
• Horses that may sustain a wound, including injection site abscesses, umbilical infections, puncture wounds, and castration sites

BotVax® B provides simple and safe protection against type B² equine botulism

• The only USDA-approved3 vaccine for equine botulism
• Sold exclusively to licensed veterinarians since 1987
• Safe to administer to healthy adult horses, pregnant mares, and foals two weeks of age and older
• Three-dose initial series with single annual booster thereafter
• Protects against all modes of Type B equine botulism
• Forage poisoning
• Shaker foal syndrome (Toxicoinfectious botulism)
• Wound botulism
• Botulism is included in The American Association of Equine Practitioners Vaccination Guidelines